Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China
· Delayed Price · Currency is CNY 9.64
-0.54 (-5.30%)
Apr 29, 2026, 3:00 PM CST
SHA:603229 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 108.03 | 130.57 | 206.79 | 253.9 | 235.38 | 145.93 | Upgrade
|
| Depreciation & Amortization | 74.19 | 74.19 | 63.52 | 40.59 | 34.48 | 30.02 | Upgrade
|
| Other Amortization | - | - | 0.14 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 1.58 | 0.52 | Upgrade
|
| Asset Writedown & Restructuring Costs | 21.56 | 21.56 | 9.56 | 5.62 | 4.95 | 5.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | -22.28 | -22.28 | -28.05 | -0.4 | -5.4 | -7.9 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 7.26 | 0.34 | - | - | Upgrade
|
| Other Operating Activities | 10.83 | 24.38 | -3.95 | -3.68 | -35.46 | 7.37 | Upgrade
|
| Change in Accounts Receivable | -9.12 | -9.12 | -23.03 | 34.45 | -69.41 | -101.89 | Upgrade
|
| Change in Inventory | -16.93 | -16.93 | -45.59 | -79.38 | -153.14 | -56.99 | Upgrade
|
| Change in Accounts Payable | -42.4 | -42.4 | -6.19 | -26.04 | 97.47 | 151.35 | Upgrade
|
| Change in Other Net Operating Assets | -0.09 | -0.09 | - | - | - | - | Upgrade
|
| Operating Cash Flow | 120.43 | 156.51 | 177.93 | 221.85 | 120.57 | 173.9 | Upgrade
|
| Operating Cash Flow Growth | -21.28% | -12.04% | -19.80% | 84.00% | -30.67% | 25.59% | Upgrade
|
| Capital Expenditures | -94.86 | -104.45 | -111.3 | -163.47 | -271.91 | -310.85 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.11 | 0.11 | 0.04 | 0.19 | 0.19 | 0.21 | Upgrade
|
| Investment in Securities | 2.01 | - | -2.25 | -18 | 95.69 | -114.72 | Upgrade
|
| Other Investing Activities | 43.9 | 45.91 | -6.46 | 5.81 | -1.81 | -6.94 | Upgrade
|
| Investing Cash Flow | -48.84 | -58.42 | -119.97 | -175.47 | -177.85 | -432.3 | Upgrade
|
| Short-Term Debt Issued | - | - | 270.1 | 330 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 505.18 | - | - | 235.05 | 219.8 | Upgrade
|
| Total Debt Issued | 516.39 | 505.18 | 270.1 | 330 | 235.05 | 219.8 | Upgrade
|
| Short-Term Debt Repaid | - | - | -300 | -271.7 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -320.36 | -0.94 | -0.63 | -103.15 | -151 | Upgrade
|
| Total Debt Repaid | -321.4 | -320.36 | -300.94 | -272.33 | -103.15 | -151 | Upgrade
|
| Net Debt Issued (Repaid) | 194.99 | 184.83 | -30.84 | 57.67 | 131.9 | 68.8 | Upgrade
|
| Issuance of Common Stock | - | - | - | 473.93 | - | - | Upgrade
|
| Common Dividends Paid | -92.21 | -90.62 | -84.22 | -57.45 | -37.67 | -19.97 | Upgrade
|
| Other Financing Activities | -29.61 | -43.75 | 6.84 | -4.23 | 0.69 | -11.8 | Upgrade
|
| Financing Cash Flow | 73.16 | 50.45 | -108.22 | 469.93 | 94.92 | 37.03 | Upgrade
|
| Foreign Exchange Rate Adjustments | -43.38 | -17.46 | 10.84 | 7.95 | 37.18 | -10.63 | Upgrade
|
| Net Cash Flow | 101.37 | 131.08 | -39.42 | 524.25 | 74.82 | -232 | Upgrade
|
| Free Cash Flow | 25.56 | 52.06 | 66.62 | 58.38 | -151.35 | -136.95 | Upgrade
|
| Free Cash Flow Growth | -9.19% | -21.85% | 14.12% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 3.22% | 6.57% | 8.38% | 7.15% | -19.80% | -24.04% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.06 | 0.08 | 0.07 | -0.19 | -0.17 | Upgrade
|
| Cash Income Tax Paid | 34.95 | 40.89 | 13.09 | -1.39 | 6.35 | 16.06 | Upgrade
|
| Levered Free Cash Flow | -85.65 | -1.36 | -63.23 | -108.01 | -179.91 | -29.41 | Upgrade
|
| Unlevered Free Cash Flow | -85.65 | -1.36 | -58.38 | -103.01 | -176.09 | -28.49 | Upgrade
|
| Change in Working Capital | -71.9 | -71.9 | -77.34 | -74.54 | -114.96 | -7.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.